Cargando…
A Comparison of TearCare and Lipiflow Systems in Reducing Dry Eye Disease Symptoms Associated with Meibomian Gland Disease
PURPOSE: To compare TearCare and Lipiflow systems in the ability to reduce the symptoms of dry eye disease (DED) associated with meibomian gland dysfunction (MGD). METHODS: In this multicenter, masked, randomized-controlled trial, 235 subjects received a single TearCare treatment (n = 115) or a sing...
Autores principales: | Holland, Edward J, Loh, Jennifer, Bloomenstein, Marc, Thompson, Vance, Wirta, David, Dhamdhere, Kavita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440678/ https://www.ncbi.nlm.nih.gov/pubmed/36065356 http://dx.doi.org/10.2147/OPTH.S368319 |
Ejemplares similares
-
TearCare for the Treatment of Meibomian Gland Dysfunction in Adult Patients With Dry Eye Disease: A Masked Randomized Controlled Trial
por: Gupta, Preeya K., et al.
Publicado: (2022) -
A Prospective, Post-Market, Multicenter Trial (CHEETAH) Suggested TearCare(®) System as a Safe and Effective Blink-Assisted Eyelid Device for the Treatment of Dry Eye Disease
por: Karpecki, Paul, et al.
Publicado: (2020) -
Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial
por: Tauber, Joseph, et al.
Publicado: (2020) -
A novel system, TearCare(®), for the treatment of the signs and symptoms of dry eye disease
por: Badawi, David
Publicado: (2018) -
TearCare(®) system extension study: evaluation of the safety, effectiveness, and durability through 12 months of a second TearCare(®) treatment on subjects with dry eye disease
por: Badawi, David
Publicado: (2019)